Yufei Wang
Dana-Farber Cancer Institute(US)
Publications by Year
Research Areas
CAR-T cell therapy research, SARS-CoV-2 and COVID-19 Research, Hepatitis B Virus Studies, HIV Research and Treatment, Immunotherapy and Immune Responses
Most-Cited Works
- → Rare variants of large effect in BRCA2 and CHEK2 affect risk of lung cancer(2014)479 cited
- → A genome-wide association study identifies six susceptibility loci for chronic lymphocytic leukemia(2008)360 cited
- → CD40 Is a Cellular Receptor Mediating Mycobacterial Heat Shock Protein 70 Stimulation of CC-Chemokines(2001)270 cited
- → Recent progress in the antiviral activity and mechanism study of pentacyclic triterpenoids and their derivatives(2018)214 cited
- → A genome-wide association study identifies multiple susceptibility loci for chronic lymphocytic leukemia(2013)187 cited
- → Discovery of Pentacyclic Triterpenoids as Potential Entry Inhibitors of Influenza Viruses(2014)153 cited
- → Silencing of MicroRNA-21 confers the sensitivity to tamoxifen and fulvestrant by enhancing autophagic cell death through inhibition of the PI3K-AKT-mTOR pathway in breast cancer cells(2015)117 cited
- → A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection(2016)111 cited
- → A Novel Nanobody Targeting Middle East Respiratory Syndrome Coronavirus (MERS-CoV) Receptor-Binding Domain Has Potent Cross-Neutralizing Activity and Protective Efficacy against MERS-CoV(2018)103 cited
- → Recombinant Receptor-Binding Domains of Multiple Middle East Respiratory Syndrome Coronaviruses (MERS-CoVs) Induce Cross-Neutralizing Antibodies against Divergent Human and Camel MERS-CoVs and Antibody Escape Mutants(2016)87 cited